Abbas, J <br/><br/>
Candida krusei fungemia. An escalating serious infection in immunocompromised patients.  [electronic resource] 

 -  Archives of internal medicine  Sep 2000 
 - 2659-64 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0003-9926 
<br/><br/><label>Standard No.: </label>10.1001/archinte.160.17.2659  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Amphotericin B--therapeutic use<br/>Antifungal Agents--therapeutic use<br/>Antineoplastic Agents--adverse effects<br/>Candida albicans--drug effects<br/>Case-Control Studies<br/>Catheterization, Central Venous--adverse effects<br/>Catheters, Indwelling--adverse effects<br/>Child<br/>Child, Preschool<br/>Drug Resistance, Microbial<br/>Female<br/>Fluconazole--therapeutic use<br/>Fungemia--drug therapy<br/>Hematologic Neoplasms--therapy<br/>Humans<br/>Immunocompromised Host<br/>Immunosuppressive Agents--adverse effects<br/>Infant<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Neutropenia--etiology<br/>Prognosis<br/>Retrospective Studies<br/>Risk Factors<br/>Shock, Septic--etiology<br/>Treatment Outcome